Skip to main content

Movers & Shakers: Oct 21, 2011

Premium

Agilent this week awarded Michael MacCoss $75,000 as part of its 2011 eMerging Insights grant program in support of his work on open source data-integration tools.

MacCoss is an assistant professor at the University of Washington and the developer of the Skyline Targeted Proteomics Environment – an open-source proteomics software platform for building selected reaction-monitoring mass spec assays.

Entitled "Validating Protein Pathway Information: Integrating Proteomic Data with Transcriptomic or Metabolomic Data Sets," the grant will aid MacCoss's efforts to expand Skyline's offerings to include analysis of genomic and metabolomic data using Agilent's GeneSpring software.


Microfluidic immunoassay firm Gyros has appointed Jon-Sverre Schanche as chief technology officer and vice president of technical affairs. Nils Kristensen, chief operating officer and vice president of technical operations; and Stephan Hoffmann, vice president of business development, are both leaving the company.

Previously Schanche was vice president of R&D at Dako Denmark A/S. Before that he was vice president of R&D at Personal Chemistry and Biotage.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.